ARCHIVES

In Brief: Final appropriations for NCI Still Probably $875 Million; US-USR Drug Book Available

This article is from The Cancer Letter archive.

Vol. 03 No. 26 | July 1, 1977

Download PDF Visit The Full Archive

Related Articles

Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis

December 27, 2013

President’s Budget Versus NCI’s Bypass: A Comparison

February 21, 1992

Alimta/Cisplatin Chemotherapy Increased Overall Survival

June 29, 2012

Better Access Key To Higher Survival For African-Americans With Colon Cancer

August 30, 2002

NCI Promises Strong Monitoring Process Visco Calls For Independent Review; Rep. Dingell Plans Hearing April 13

April 1, 1994

Susan Weiner Named to HHS Panel

January 17, 2003